Skip to main content
SpringerLink
Log in

Bladder Cancer: Overview, Epidemiology, Initial Presentation and Diagnosis

  • Chapter
  • First Online:
Chemotherapy and Immunotherapy in Urologic Oncology

Abstract

Bladder cancer, also known as urothelial carcinoma, is the most common malignancy of the genitourinary system. It can occur anywhere along the urothelial lining, including the kidneys, ureters, bladder, and urethra. Bladder cancer is the ninth most common cancer worldwide and sixth most common cancer in the United States. Transitional cell carcinoma is the most common type of urothelial carcinoma. Histologic variants of bladder cancer are harder and aggressive to treat. Squamous cell carcinoma is the most common type of non-urothelial carcinoma. Smoking is one of the major risk factors for the development of bladder cancer, and smokers are three times more susceptible to developing bladder cancer compared to nonsmokers. The mortality rate for urothelial cancer has decreased by 5% mainly because of awareness, which helped with smoking cessation, changes in environmental carcinogens, healthier lifestyles, better access to treatments, and better choice of chemotherapy for metastatic urothelial cancer patients to name a few. In terms of diagnosing urothelial carcinoma, a complete urological evaluation with complete history and physical, laboratory tests including microscopic analysis, urine culture, and cytology is warranted. Complete workup involves computed tomography (CT) urogram and cystoscopy as the final steps of evaluation. Gross hematuria and asymptomatic hematuria are one of the key elements of clinical presentation, as well as other irritative urinary symptoms. Early detection of bladder cancer is the key to have a favorable prognosis and to prevent metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108.

    Article  PubMed  Google Scholar 

  2. American Cancer Society. Cancer facts and figures 2018. Atlanta: American Cancer Society; 2018. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2018.html.

  3. Parkin DM. The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl. 2008;218:12–20.

    Article  Google Scholar 

  4. Malats N, Real FX. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 2015;29(2):177–89, vii

    Article  PubMed  Google Scholar 

  5. Wein AJ, Kavoussi LR, Partin AW, Peters CA. Tumors of the bladder. In: McDougal WS, Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2015.

    Google Scholar 

  6. Lajiness M, Quallich S. The nurse practitioner in urology. New York: Springer; 2016.

    Book  Google Scholar 

  7. Tang H, Shi W, Fu S, Wang TW, Zhai S, Song Y, et al. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis. Cancer Med. 2018;7(4):1070–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15:25–41.

    Article  CAS  PubMed  Google Scholar 

  9. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.

    Article  PubMed  Google Scholar 

  11. Jones TD, Zhang S, Lopez-Beltran A, Eble JN, Sung MT, MacLennan GT, et al. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol. 2007;31(12):1861–7.

    Article  PubMed  Google Scholar 

  12. Picozzi S, Casellato S, Bozzini G, Ratti D, Macchi A, Rubino B, et al. Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients. Urol Oncol. 2013;31(8):1584–90.

    Article  PubMed  Google Scholar 

  13. Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology. 1998;52(6):1009–13; discussion 13-4

    Article  CAS  PubMed  Google Scholar 

  14. Klaile Y, Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM. Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol. 2016;5(5):692–701.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Johansson SL, Borghede G, Holmang S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol. 1999;161(6):1798–802.

    Article  CAS  PubMed  Google Scholar 

  16. Terada T. Nested variant of urothelial carcinoma of the urinary bladder. Rare Tumors. 2011;3(4):e42.

    PubMed  PubMed Central  Google Scholar 

  17. Lopez-Beltran A, Cheng L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol. 2006;37(11):1371–88.

    Article  CAS  PubMed  Google Scholar 

  18. Wang Z, Lu T, Du L, Hu Z, Zhuang Q, Li Y, et al. Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review. Int J Clin Exp Pathol. 2012;5(6):601–8.

    PubMed  PubMed Central  Google Scholar 

  19. Keck B, Wach S, Stoehr R, Kunath F, Bertz S, Lehmann J, et al. Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. BMC Cancer. 2013;13:71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Abol-Enein H. Infection: is it a cause of bladder cancer? Scand J Urol Nephrol Suppl. 2008;218:79–84.

    Article  Google Scholar 

  21. Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP, et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol. 1977;118(6):967–71.

    Article  CAS  PubMed  Google Scholar 

  22. Bickel A, Culkin DJ, Wheeler JS Jr. Bladder cancer in spinal cord injury patients. J Urol. 1991;146(5):1240–2.

    Article  CAS  PubMed  Google Scholar 

  23. Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, et al. Review of the M.D. Anderson experience in the treatment of bladder sarcoma. Urol Oncol. 2007;25(1):38–45.

    Article  PubMed  Google Scholar 

  24. Morelli O, Castellani D, Asciutti S, Baldoni M, Familiari L, Nardi E, et al. Colon and gastric metastases from a primary signet-ring cell carcinoma of the urinary bladder. Dig Liver Dis. 2006;38(8):609–11.

    Article  CAS  PubMed  Google Scholar 

  25. Thota S, Kistangari G, Daw H, Spiro T. A clinical review of small-cell carcinoma of the urinary bladder. Clin Genitourin Cancer. 2013;11(2):73–7.

    Article  PubMed  Google Scholar 

  26. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  27. American Cancer Society. Bladder cancer risk factors. Atlanta: American Cancer Society; 2016. Available from: https://www.cancer.org/cancer/bladder-cancer/causes-risks-prevention/risk-factors.html.

  28. Letasiova S, Medve’ova A, Sovcikova A, Dusinska M, Volkovova K, Mosoiu C, et al. Bladder cancer, a review of the environmental risk factors. Environ Health. 2012;11 Suppl 1:S11.

    Article  PubMed  Google Scholar 

  29. Riesz P, Lotz G, Paska C, Szendroi A, Majoros A, Nemeth Z, et al. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique. Pathol Oncol Res. 2007;13(3):187–94.

    Article  PubMed  Google Scholar 

  30. MacVicar AD. Bladder cancer staging. BJU Int. 2000;86(Suppl 1):111–22.

    PubMed  Google Scholar 

  31. Nargund VH, Raghavan D, Sandler HM. Urological oncology. London: Springer-Verlag; 2015.

    Google Scholar 

  32. Siefker-Radtke A. Urachal adenocarcinoma: a clinician’s guide for treatment. Semin Oncol. 2012;39(5):619–24.

    Article  CAS  PubMed  Google Scholar 

  33. Bhat S, Sathyanarayanaprasad M, Paul F. Primary squamous cell carcinoma of bladder exstrophy in an adult. Indian J Urol. 2015;31(2):142–3.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Parekh DJ, Jung C, O’Conner J, Dutta S, Smith ER Jr. Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology. 2002;60(1):164.

    Article  PubMed  Google Scholar 

  35. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289–93.

    Article  PubMed  PubMed Central  Google Scholar 

  36. American Cancer Society. Early detection, diagnosis, and staging: bladder cancer signs and symptoms. Atlanta: American Cancer Society; 2019. Available from: https://www.cancer.org/cancer/bladder-cancer/detection-diagnosis-staging/signs-and-symptoms.html.

  37. Goodison S, Rosser CJ, Urquidi V. Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests. Mol Diagn Ther. 2013;17(2):71–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Cha K, Hadjiiski L, Chan HP, Cohan RH, Caoili EM, Zhou C. Detection of urinary bladder mass in CT urography with SPAN. Med Phys. 2015;42(7):4271–84.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

    Article  CAS  PubMed  Google Scholar 

  40. American Cancer Society. Medical student curriculum: hematuria. Linthicum: American Urological Association; 2016. Available from: https://www.auanet.org/education/auauniversity/for-medical-students/medical-student-curriculum/hematuria.

Download references

Author information

Authors and Affiliations

  1. The Pennsylvania State University, College of Medicine, Department of Surgery, Division of Urology, Hershey, PA, USA

    Betsy M. Avinash, Jay D. Raman & Matthew G. Kaag

Authors
  1. Betsy M. Avinash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jay D. Raman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew G. Kaag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Betsy M. Avinash .

Editor information

Editors and Affiliations

  1. Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA

    Edouard J. Trabulsi

  2. Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA

    Costas D. Lallas

  3. Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA

    Anne E. Lizardi-Calvaresi

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Avinash, B.M., Raman, J.D., Kaag, M.G. (2021). Bladder Cancer: Overview, Epidemiology, Initial Presentation and Diagnosis. In: Trabulsi, E.J., Lallas, C.D., Lizardi-Calvaresi, A.E. (eds) Chemotherapy and Immunotherapy in Urologic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-52021-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-52021-2_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-52020-5

  • Online ISBN: 978-3-030-52021-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation